AMPH vs CPRT · P/E 12, rev $732.0M vs P/E 19, $28.66B cap
Amphastar P (AMPH) versus Copart Inc (CPRT) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Copart Inc (CPRT) is a specialty business services company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
CPRT does not have a complete income-statement cache yet.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Not investment advice. Open the AMPH and CPRT stock pages for the full models.
Not investment advice.